About
Chief Business Development Officer at Aspeya with over 20 years of pharmaceutical development experience, including 18 years at Novartis in business development and licensing; holds a Ph.D. in Drug Delivery.
Colleagues at Invivo Capital Partners
Albert Ferrer
Partner at Invivo Capital Partners
Borja Ruiz
Investment Analyst at Invivo Capital Partners
Cinta Diez
Investment Analyst at Invivo Capital Partners
Gemma Guinart
Principal at Invivo Capital Partners
Josep M. Martorell
Partner at Invivo Capital Partners
Laura Rodríguez
Partner at Invivo Capital Partners
Luis Pareras
Managing Partner at Invivo Capital Partners
Luis Serrano
Director, CRG (Centre for Genomic Regulation) at Invivo Capital Partners